| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A critical evaluation of glucocorticoids in the management of severe COVID-19
|
Solinas, Cinzia
|
|
|
54 |
C |
p. 8-23
|
artikel
|
| 2 |
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization
|
Johnson, Betcy Susan
|
|
|
54 |
C |
p. 32-42
|
artikel
|
| 3 |
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
|
Aricò, Eleonora
|
|
|
54 |
C |
p. 43-50
|
artikel
|
| 4 |
COVID-19 infection may increase the risk of parkinsonism – Remember the Spanish flu?
|
Eldeeb, Mohamed A.
|
|
|
54 |
C |
p. 6-7
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
54 |
C |
p. ii
|
artikel
|
| 6 |
IL-15 immunotherapy is a viable strategy for COVID-19
|
Kandikattu, Hemanth Kumar
|
|
|
54 |
C |
p. 24-31
|
artikel
|
| 7 |
Letter to the Editor on “Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev”
|
Quiros-Roldan, Eugenia
|
|
|
54 |
C |
p. 1-2
|
artikel
|
| 8 |
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
|
Costela-Ruiz, Víctor J.
|
|
|
54 |
C |
p. 62-75
|
artikel
|
| 9 |
Should we unstress SARS-CoV-2 infected cells?
|
Csukasi, Fabiana
|
|
|
54 |
C |
p. 3-5
|
artikel
|
| 10 |
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
|
Goker Bagca, Bakiye
|
|
|
54 |
C |
p. 51-61
|
artikel
|
Tijdschrift beschrijving